Westfair OnlineGene therapy cancer treatment funded by Stamford nonprofit awaits FDA approvalWestfair OnlineIn Stamford, the Alliance for Cancer Gene Therapy since 2004 has provided a total of $1.8 million to Dr. Carl June at the University of Pennsylv… Continue reading
Novel Stem Cell Method May Offer an Alternative to Treat Cancer MetastasisSpecialty Pharmacy TimesIn a study published in Science Translational Medicine, investigators programmed human bone marrow stem cells to identify the unique properties of cancero… Continue reading
The Economist |
A rush for immunotherapy cancer drugs means new bedfellows
The Economist Pharma frenemies. A rush for immunotherapy cancer drugs means new bedfellows. Fierce rivals in pharma are co-operating. Aug 5th 2017. See article. Readers’ comments. The Economist welcomes your views. Please stay on topic and be respectful of other … |
The Economist |
A rush for immunotherapy cancer drugs means new bedfellows
The Economist The drug, Imfinzi, and the experimental drug tremelimumab, belong to a new category of immunotherapy medicines called “checkpoint inhibitors”. Similar drugs are made by Bristol Myers Squibb (BMS), by Merck in America and Roche, a Swiss firm. AstraZeneca plc: Buy the Dip?Madison.com |
New Scientist |
The slime mould instruments that make sweet music
New Scientist Miranda would like to be able to “tune” the predictability of the output at will; that might be more feasible if the mechanism behind moulds’ memristance can be identified and replicated in a controlled manner using the tools of synthetic biology. All … |